• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

EXENATIDE

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

AGING IL17A BREAST CANCER CANDIDA ALBICANS INSULIN CANCER CELL DIVISION RECEPTOR AUTOPHAGY TP53 TNF IL23A DIABETES MELLITUS IL6 ALZHEIMER'S DISEASE PSEUDOMONAS AERUGINOSA CTLA4 FOXP3 HELICOBACTER PYLORI APOPTOTIC PROCESS CASP3 LISTERIA MONOCYTOGENES REMICADE IMMUNE RESPONSE PARKINSON DISEASE RHEUMATOID ARTHRITIS CLOSTRIDIUM DIFFICILE STAPHYLOCOCCUS AUREUS CD4 ESCHERICHIA COLI 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE INFLAMMATION IFNG CELL PROLIFERATION PORPHYROMONAS GINGIVALIS NEURODEGENERATIVE DISORDERS METFORMIN STREPTOCOCCUS PNEUMONIAE DOXORUBICIN SOD1 ANGIOGENESIS ERBB-2 TH17 CELLS CELL DEATH CELL DIFFERENTIATION

© 2020 Biovista Vizit All Rights Reserved.